MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer
暂无分享,去创建一个
Hiroshi Tanaka | Hiroshi Mizushima | Kenichi Sugihara | Kaoru Mogushi | S. Iida | K. Sugihara | Hiroshi Tanaka | H. Uetake | Toshiaki Ishikawa | Satoru Iida | Hiroyuki Uetake | K. Mogushi | H. Mizushima | Takatoshi Matsuyama | Tsuyoshi Yoshida | T. Matsuyama | T. Ishikawa | Tsuyoshi Yoshida
[1] M. Somerfield,et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Gotley,et al. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. , 1999, Cancer research.
[3] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[4] Susumu Goto,et al. The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..
[5] M. Tsao,et al. Expression profiling by microarrays in colorectal cancer (Review). , 2005, Oncology reports.
[6] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[7] Baljit Singh,et al. Oncogenic β-Catenin Is Required for Bone Morphogenetic Protein 4 Expression in Human Cancer Cells , 2002 .
[8] J. Astola,et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. , 2005, Gastroenterology.
[9] Y. Miki,et al. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy , 2008, The British journal of surgery.
[10] M. Yasuno,et al. Expression of 5-lipoxygenase in human colorectal cancer. , 2006, World journal of gastroenterology.
[11] T. Akiyama,et al. Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. , 2008, World journal of gastroenterology.
[12] Gerhard Christofori,et al. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.
[13] D. Hirsch,et al. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. , 1997, Biochemical and biophysical research communications.
[14] L. Packer,et al. Expression of the cell surface mucin gene family in adenocarcinomas. , 2004, International journal of oncology.
[15] L. Lipton,et al. Adjuvant therapies for colorectal cancer. , 2007, World journal of gastroenterology.
[16] Emery H Bresnick,et al. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene. , 2004, Molecular immunology.
[17] A. Knudson,et al. Optimized procedures for microarray analysis of histological specimens processed by laser capture microdissection , 2004, Journal of cellular physiology.
[18] S. Rudman,et al. Targeted therapy in colorectal carcinoma: more than a theory , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[19] F. Révillion,et al. Prognostic Value of ERM Gene Expression in Human Primary Breast Cancers , 2004, Clinical Cancer Research.
[20] Michael A. Hollingsworth,et al. Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.
[21] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[22] David C. Atkins,et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] V. Gouyer,et al. Architecture of the large membrane-bound mucins. , 2008, Gene.
[24] W. Zimmermann,et al. Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis. , 1997, Cancer research.
[25] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[26] E. Wolski,et al. Normalization strategies for cDNA microarrays. , 2000, Nucleic acids research.
[27] T Tanaka,et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. , 2001, Cancer research.
[28] Daniel L. Hartl,et al. GeneMerge - Post-genomic Analysis, Data Mining, and Hypothesis Testing , 2003, Bioinform..
[29] B. Dieckgraefe,et al. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis , 2008, International journal of cancer.
[30] Katsuhiko Yanaga,et al. Clinical Significance of TROP2 Expression in Colorectal Cancer , 2006, Clinical Cancer Research.
[31] M. Weinstein,et al. Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US , 2007, Cancer.
[32] B. Wolpin,et al. Systemic treatment of colorectal cancer. , 2008, Gastroenterology.
[33] T R Fleming,et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] J. Burgess,et al. New developments in the analysis of gene expression , 2000, Redox report : communications in free radical research.
[35] J Quackenbush,et al. Effects of ischemia on gene expression. , 2001, The Journal of surgical research.
[36] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[37] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[38] Baljit Singh,et al. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. , 2002, Cancer research.
[39] J. Hardcastle,et al. Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.